Mbn hiv/aids evaluation final report Team of consultants



Yüklə 0,97 Mb.
səhifə32/92
tarix05.01.2022
ölçüsü0,97 Mb.
#71142
1   ...   28   29   30   31   32   33   34   35   ...   92
2001

2004

Total number of counterparts

Total budget

Euro

Total number of counterparts

Total budget

Euro

ICCO













HIV/AIDS counterparts funded

SAN funds


110


11

1,776,00.00

203,895.00

157


10

3,047,700.00

526,580.00


All partners funded

974

84,044,622.00

832

97,800,133.00

% of HIV/AIDS counterparts to all

12.43 %



20.07%





% of HIV/AIDS funds to all funds



2.36%




3.65%


NOVIB













HIV/AIDS counterparts funded

SAN funds


92

2


2,915,219.78

453,780.22

119


11

5,262,56.00

647,844.00


All partners funded

894

124,000,000.00

842

122,000,000.00

% of HIV/AIDS counterparts to all

10.51%



15.44%




% of HIV/AIDS funds to all funds



2.72%




4.84%


CORDAID













HIV/AIDS counterparts funded

SAN funds


22

8


4,033,298.00

466,702.00

33

17


9,531,000.00

454,000.00


All partners funded

1.011

146,874,000.00

776

153,809,000.00

% of HIV/AIDS counterparts to all

2.97%




6.44%





% of HIV/AIDS funds to all funds



3.06%




6.49%


HIVOS













HIV/AIDS counterparts funded

SAN funds


76

10


2,190,859.00

539,008.00

108


17

3,487,364.00

683,120,00


All partners funded

735

59,456,253.00

825

66,099,659.00

% of HIV/AIDS counterparts to all

11.70%




15.15%





% of HIV/AIDS funds to all funds



4.59%




6.31%


TOTAL 4 CFA













HIV/AIDS counterparts funded


329


13,089,345.00


473


24,652,424.00

All partners funded

3614

414,374,875.00

3275

439,708,792.00

% of HIV/AIDS counterparts to all

9.10%




14.44%





% of HIV/AIDS funds to all funds




3.16%





5.60%

PLAN (2)













HIV/AIDS related programmes of Plan country offices

4 (estimated 15 local counterparts receiving funds)

655,919.00

46 (estimated 74 local counterparts receiving funds)

4,943,681.00

HACI for 2.500.000 euro included



Total number of programmes of Plan Country Offices funded by Plan NL

72 programmes (number of all counterparts unknown)


6.830.335,00


234 programmes (number of all counterparts unknown)


22,311,018.00



% of HIV/AIDS funded programmes to all programmes

5.56%




19,66%





% of HIV/AIDS funds to all funds




9.60%




22,16%

Remarks: (1) Total number of counterparts funded in all the countries: (1) AIDS- focussed organisations and (2) organisations with integrated AIDS work (integrated AIDS work is used to mean AIDS work which is implemented along with, or as part of, development work. The focus is on direct prevention, care, treatment or support, but with the difference that the work is conducted in conjunction with, and linked to, other projects or within wider programmes)..

(2) In this table Plan Netherlands is presented on its own and separated from the other 4 CFAs. Their approach is not to work directly with counterparts but to fund programmes of Plan Country Offices that are connected to counterparts and CBOs. Plan NL is not a member of Stop Aids Now (SAN) and did not receive funding from SAN for their programmes in the South.
Between 2001 and 2004 all CFAs have significantly increased the number of HIV/AIDS counterparts as well as the total amount of money funded. In general, counterparts and funds have increased by +/- 50% in four years time. Also additional SAN! funds have increased in this period. The more than proportional increase of Plan money is mainly due to the important funding in 2004 of the regional HACI7 (Hope for African Children Initiative) programme with 2.500.000 euro.
Based on the interviews with staff, the evaluators learned that it was up to the regional departments to make choices and allocate or re-allocate resources to specific programmes such as HIV/AIDS. In this period Cordaid and Novib concentrated on Africa, where many countries had entered the generalised phase of the HIV/AIDS epidemic. PLAN and Icco started to expand to other continents. Hivos already had HIV/AIDS extensive programmes in Latin America and Asia, steered to specific (high risk) target groups.
Amount of sharing and learning initiatives

The following table shows sharing and learning initiatives per CFA and for the four selected countries (details of this table can be found in the annex under table 4)


Table 7a: Overview of budgets related to (HIV/AIDS) sharing and learning initiatives of the 5 CFAs in the four selected countries during the period 2001-2004

As per CFA

Sharing and learning initiative

2001

2002

2003

2004

ICCO



















Totals for ICCO

% to total of 5 CFAs



25,310.00

24.66%


147,500.00

53.60%


162,500.00

34.44%


272,500.00

60.68%


NOVIB



















Totals for NOVIB

% to total of 5 CFAs



65,000.00

63.34%


97,000.00

35.25%


105,000.00

22.26%


112,000.00

24.94%


CORDAID



















Totals for CORDAID

% to total of 5 CFAs



10,000. 00

9.74%


25,000.00

9.09%


190,000.00

40.27%


35,000.00

7.79%


HIVOS



















Totals HIVOS

% to total of 5 CFAs



2,310.00

2.25%


5,671.00

2.06%


14,290.00

3.03%


29,553.00

6.58%


PLAN




-

-

-

-




Totals for 5 CFAs

102,620.00

275,171.00

471,790.00

449,053.00


Table 7b: Overview of budgets related to (HIV/AIDS) sharing and learning initiatives in the four selected countries during the period 2001-2004

As per country

Sharing and learning initiative

2001

2002

2003

2004

Zimbabwe

Total for Zimbabwe

% to total






5,000.00

1.82%


14,290.00

3.03%


1,558.00

0.4%


South Africa

Total for South Africa

% to total



20,000.00

19.49%


40,000.00

14.03%


210,000.00

44.51%


65,000.00

15.15%


Malawi

Total for Malawi

% to total



55,000.00

53.6%


87,671.00

31.86%


85,000.00

18.02%


45,000.00

10.49%


India

Total for India

% to total



2,310.00

2.25%





20,000.00

4.24%


44,995.00

10.49%


Regional initiatives that serve Faith Based Organisations in particular

Total regional in Africa

% to total



25,310.00

24.66%


142,500.00

51.79%


142,500.00

30.20%


272,500.00

63.51%





Total for all countries

102,620.00

275,171.00

471,790.00

429,053.00

Remark: Sharing and learning initiatives concern seminars, conferences, trainings, etc that were funded in different countries in the period 2001 to 2004 (initiatives of course that are explicitly linked to the fight against HIV/AIDS) and to which several of the counterparts were invited.
As shown in the table above, sharing and learning was also a growing activity between 2001 and 2004; the total amount even quadrupled in that period. A point of interest is the importance of regional activities in sharing and learning organised in the African region. Zimbabwe on the other hand is almost absent in this table. Plan did not fund directly such activities; nevertheless, their country offices could have organised such programmes as well as the HACI donor consortium which is heavily funded by Plan.
SAN! funds which do not appear in the table have been invested in joint learning and sharing activities, particularly the mainstreaming workshops in Ethiopia, Sudan, Uganda and India.
Novib and Cordaid have invested important additional funds in mainstreaming activities. Novib created a 1 million euro budget for supporting its counterparts (5000 euro each) in developing and implementing an internal workplace policy and to give a boost to the (internal and external) mainstreaming process. Cordaid started a big capacity building programme in Southern Africa (including workshops and a small grant), supporting its counterparts in internal and external mainstreaming. For Malawi and South Africa a total budget of 600,000 euros was allocated for four years (2001-2004).

The assessment of proposals

The response to HIV/AIDS by counterparts is not included in the appraisal systems used by the CFAs, except for Novib, which integrated the HIV/AIDS component in its grant-making toolbox 2005. However, according to the HIV/AIDS policy papers, all (new) counterparts have to be assessed on their HIV/AIDS-competence (explicit in the policy papers of Novib, Cordaid and ICCO. For Plan, HIV/AIDS is a cross-cutting issue that needs to be assessed). The assessment of the HIV/AIDS response of counterparts depends a lot on the capacity and commitment of individual staff members (programme officers). The HIV/AIDS appraisals are rather implicit and not systematic. Whether or not specific routes to mainstream HIV/AIDS will be included in project proposals depends on the responsiveness of each programme officer. Although internal training on HIV/AIDS is part of the CFAs strategy, not all programme officers interviewed showed commitement to HIV/AIDS mainstreaming.


The portfolio of HIV/AIDS related counterparts

For this evaluation exercise the CFAs were asked to elaborate a portfolio of counterparts that could give an overview of all counterparts (in South Africa, Malawi, Zimbabwe and India) who had received funding in the period 2001-2004 to facilitate the implementation of HIV/AIDS-specific services and/or to mainstream HIV/AIDS into their organisations (these portfolios are added in annex to each organisation report which are available on request). Based on this overview the evaluators have identified some trends. The evaluators have to acknowledge that they had no control over the exhaustiveness of these overviews elaborated by each CFA. They will not do a financial analysis on these data as most of the organisations receive budget support, but many of them are generalist organisations not only involved in HIV/AIDS specific activities. It was impossible to contribute percentages of the budget support to the HIV/AIDS-specific interventions (only Hivos and Cordaid work with estimation of percentages of the whole budget that is spent on HIV/AIDS-related activities).


Table 8: Overview of the amount of generalist counterparts funded versus AIDS specific counterparts funded by four CFAs in the four countries visited, according to the portfolio of counterparts funded in the four countries visited during the period 2001-2004.




HIVOS

(n=45)

NOVIB

(n=25)

CORDAID (n=27)

ICCO

(n=35)

Total

(n=132)

Generalist counterparts

31

69%

18

72%

21

78%

30

86%

100

76%

HIV/AIDS specific counterparts

14

31%

7

28%

6

22%

5

14%

32

24%

Remark: Plan is not integrated in this table as Plan has no direct contact with counterparts. The Plan Country offices are responsible for the implementation of the programmes and the follow up of the counterparts. Plan programme officers do assess the capacity of counterparts as described in programme outlines and visit some of them during field visits but these programme officers are not directly involved in the relationship with the counterparts. The evaluators received information on the programmes but not detailed information on every counterparts involved in these programmes.
Conclusions on table 8:

  • The generalist counterparts outnumber the HIV/AIDS specific counterparts in the CFA’s portfolios for South Africa, Zimbabwe, Malawi and India. This demonstrates that in countries that have entered the generalised phase of the HIV/AIDS epidemic, all organisations are confronted with HIV/AIDS and have to find responses to this generalised epidemic. Many generalist counterparts started to integrate (or mainstream) HIV/AIDS activities in their programmes and this process has been stimulated and funded by the CFAs.

  • The focus of Hivos on HIV/AIDS specific organisations is confirmed in this overview, with a share of 31% HIV/AIDS specific counterparts. However, in Southern Africa, Hivos also supports many generalist organisations.


Table 9a: Nature of HIV/AIDS activities counterparts of four CFAs are implementing in Southern Africa (Zimbabwe, Malawi and South Africa), according to the portfolio of counterparts funded in the four countries visited during the period 2001-2004.

HPR

NOVIB (n= 21)

# %

HIVOS (n=36*)

# %

CORDAID (n=22*)

# %

ICCO (n=23*)

# %

Total (n=102)

# %

Prevention

19

90%

13

36%

12

55%

14

61%

58

57%

Care

13

62%

6

17%

12

55%

12

52%

43

42%

Treatment

1

0,05%

3

0,08%

2

10%

4

17%

10

10%

Advocacy and lobby

8

38%

26

72%

5

23%

11

48%

50

49%

Remark: (1) For HIVOS and ICCO, we did not receive information on the activities concerning prevention, care and treatment of all counterparts. For HIVOS information is lacking on 17 counterparts, for ICCO on 5 counterparts (2) For Cordaid 8 out of 22 counterparts were in particular funded for mainstreaming efforts or research.


Table 9b: nature of HIV/AIDS activities counterparts are implementing in India, according to the portfolio of counterparts funded in the four countries visited during the period 2001-2004.

LPR

NOVIB (n= 4)

# %

HIVOS (n=9)

# %

CORDAID (n=5)

# Total

ICCO (n=12)

# %

Total (n=30)

# %

Prevention

4

100%

6

67%

4

80%

12

100%

26

87%

Care

0

0

5

56%

3

60%

4

33%

12

40%

Treatment

0

0

4

44%

1

20%

3

25%

8

27%

Advocacy and lobby

2

50%

7

78%

1

20%

3

25%

13

43%

Remark: For HIVOS we did not receive information on the activities of all counterparts.
The following trends can be recognized:

  • Table 9a-Southern Africa (high prevalence region): Most of the counterparts are involved in a mix of activities, covering the whole continuum from prevention to care, in particular the counterparts of Cordaid and ICCO. Regarding Novib and Hivos, prevention activities are more represented than activities related to care and treatment. Not many counterparts are actively involved in treatment (facilitating access to treatment or organising ARV sites).

  • Table 9b-India (low prevalence region): In India focus is very much on prevention activities, in particular for Novib and ICCO (prevention concerns awareness building, HIV/AIDS education, fighting discrimination, offering VCT and counselling services). More counterparts are facilitating access to treatment, compared to the data of the high prevalence region.

  • Advocacy and lobby activities constitute an important part of the counterpart’s activities. Many counterparts that offer HIV/AIDS related services are also involved in lobby and advocacy. Lobby and advocacy is the main focus of Hivos portfolio. Advocacy and lobby activities take also an important share in the portfolio of Novib and ICCO.

  • Plan is not included in this overview as they fund programmes elaborated by the Plan country offices and implemented by the Plan team themselves or through counterparts. Plan International has developed the Circle of Hope approach which covers activities related to prevention, care, treatment and impact mitigation, and particularly directed at OVCs and their families.


Table 9c: Nature of HIV/AIDS activities of HIV/AIDS specific counterparts (H/A) on the one hand and generalist counterparts (Ge) on the other hand of four CFAs implemented in Southern Africa (Zimbabwe, Malawi and South Africa), according to the portfolio of counterparts funded in the four countries visited during the period 2001-2004.

HPR

NOVIB(n= 21)

HIVOS (n=36*)

CORDAID n=22*)

ICCO (n=23*)

Total (n=102)

H/A

# 6


Ge

# 15


H/A

# 11


Ge

# 25


H/A

# 4


Ge

# 18


H/A

# 5


Ge

# 18


H/A

# 26


Ge

# 76


Prevention

6

13

8

5

4

8

4

10

22

36

Care

4

9

5

1

4

8

4

8

17

26

Treatment

1

0

1

0

2

0

3

1

7

3

Advocacy and lobby

3

5

10

16

2

3

2

9

17

33

Remark: (1) H/A = HIV/AIDS specific counterparts and Ge= generalist counterparts (2) For HIVOS and ICCO, we did not receive information on the activities concerning prevention, care and treatment of all counterparts. For HIVOS information is lacking on 17 counterparts, for ICCO on 5 counterparts (3) For Cordaid 8 out of 22 counterparts were in particular funded for mainstreaming efforts or research.

Table 9D: Nature of HIV/AIDS activities of HIV/AIDS specific counterparts (H/A) on the one hand and generalist counterparts (Ge) on the other hand of four CFAs implemented in India, according to the portfolio of counterparts funded in the four countries visited during the period 2001-2004.

LPR (India)

NOVIB(n= 4)

HIVOS (n=9)

CORDAID (n=5)

ICCO (n=12)

Total (n=30)

H/A

# 1


Ge

# 3


H/A

# 3


Ge

# 6


H/A

# 2


Ge

# 3


H/A

# 0


Ge

# 12


H/A

# 6


Ge

# 24


Prevention

1

3

2

4

2

2

/

12

5

21

Care

0

0

2

3

2

1

/

4

4

8

Treatment

0

0

2

2

0

1

/

3

2

6

Advocacy and lobby

0

2

2

5

1

0

/

3

3

10

Remark: (1) H/A = HIV/AIDS specific counterparts and Ge= generalist counterparts (2) For HIVOS we did not receive information on the activities of all counterparts

Conclusions regarding Table 9c and 9d: comparison between the activities implemented by HIV/AIDS focussed organisations and generalist organisations:



  • HIV/AIDS focussed organisations as well as generalist organisations are involved in advocacy and lobby. The evaluators could witness during the field visits the different scope of these advocacy and lobby activities. Whereas HIV/AIDS focussed organisations lobby around specific HIV/AIDS issues (like access to treatment, discrimination of PLWHA), many generalist organisations lobby other issues that indirectly have an impact on the lives of PLWHA, for example, Cordaid’ counterpart The Black Sash (South Africa) lobbies for the Basic Income Grant which will have a big impact on the lives of PLWHA.

  • Many generalist organisations offer HIV/AIDS related services in the field of prevention and care/support, mostly by adding HIV/AIDS related activities to their core business. Some generalist counterparts invest in mainstreaming activities, in the sense of adopting existing programmes to the HIV/AIDS context (see further under evaluation question 4). This is especially the case for the portfolio of Cordaid where 8 of the 22 counterparts were funded in particular to support these mainstreaming processes.

  • In Southern Africa the generalist organisations are not involved in treatment programmes (except the Mulanje hospital in Malawi, counterpart of ICCO, which is considered as a non specific HIV/AIDS organisation but offering HIV/AIDS treatment services lies in the scope of their core business). In India these generalist organisations are involved in treatment programmes (facilitating access to ARV sites).


Table 10: Number of women organisations or organisations who direct their activities explicitly at women, in the portfolio of Southern Africa and India in relation to the total number of HIV/AIDS counterparts funded in these countries during the period 2001-2004.




NOVIB

HIVOS

Cordaid

ICCO

Total

Number of women’s organisations

5

12

2

6

25

Total number of counterparts involved in HIV/AIDS activities

25

45

27

35

132

% of women’s organisations or women’s support organisations

20%

27%

7%

17%

19%

Remark: Plan supports programmes in which local counterparts participate to implement the activities. These programmes are managed at country level, hence no information of all counterparts is available at the level of Plan Netherlands.
The evaluators have also taken a look at the number of women organisations or women support organisations in the whole HIV/AIDS portfolio of the four countries included in this evaluation. Table 10 indicates that not much specific efforts have been developed to identify women organisations or women support organisations who are explicitly involved in HIV/AIDS-related activities.

Women organisations are well-represented by Hivos, followed by Novib and ICCO and to a much lesser degree by Cordaid. Regarding Plan, one of the founders of the HACI programme is the Society of Women and AIDS in Africa.


Women’s organisations or women’s support organisations can play a vital role in addressing factors that increase women’s vulnerability to HIV/AIDS. The evaluators did not analyse the portfolio of women’s organisations of the different CFAs. However an other MBN evaluation of the role of women organisations, executed in 2003, formulated a general conclusion that the number of women organisations should increase in the portfolio of the CFAs. There might be an opportunity to combine this with HIV/AIDS.


Yüklə 0,97 Mb.

Dostları ilə paylaş:
1   ...   28   29   30   31   32   33   34   35   ...   92




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin